» Articles » PMID: 24391639

Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation Than "Exhaustion" of Human CD8 T Cells

Overview
Journal Front Immunol
Date 2014 Jan 7
PMID 24391639
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Under conditions of chronic antigen stimulation, such as persistent viral infection and cancer, CD8 T cells may diminish effector function, which has been termed "exhaustion." Expression of inhibitory Receptors (iRs) is often regarded as a hallmark of "exhaustion." Here we studied the expression of eight different iRs by CD8 T cells of healthy humans, including CTLA-4, PD1, TIM3, LAG3, 2B4, BTLA, CD160, and KLRG1. We show that many iRs are expressed upon activation, and with progressive differentiation to effector cells, even in absence of long-term ("chronic") antigenic stimulation. In particular, we evaluated the direct relationship between iR expression and functionality in CD8 T cells by using anti-CD3 and anti-CD28 stimulation to stimulate all cells and differentiation subsets. We observed a striking up-regulation of certain iRs following the cytokine production wave, in agreement with the notion that iRs function as a negative feedback mechanism. Intriguingly, we found no major impairment of cytokine production in cells positive for a broad array of iRs, as previously shown for PD1 in healthy donors. Rather, the expression of the various iRs strongly correlated with T cell differentiation or activation states, or both. Furthermore, we analyzed CD8 T cells from lymph nodes (LNs) of melanoma patients. Interestingly, we found altered iR expression and lower cytokine production by T cells from metastatic LNs, but also from non-metastatic LNs, likely due to mechanisms which are not related to exhaustion. Together, our data shows that expression of iRs per se does not mark dysfunctional cells, but is rather tightly linked to activation and differentiation. This study highlights the importance of considering the status of activation and differentiation for the study and the clinical monitoring of CD8 T cells.

Citing Articles

Composite score of PD-1 CD8 tumor-infiltrating lymphocytes and CD57 CD8 tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer.

He T, Zhang J, Zeng L, Yin Z, Yu B, Zhang X Chin J Cancer Res. 2025; 37(1):73-89.

PMID: 40078557 PMC: 11893342. DOI: 10.21147/j.issn.1000-9604.2025.01.06.


Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells.

Greenberg S Oncotarget. 2025; 16():1-8.

PMID: 39832302 PMC: 11745485. DOI: 10.18632/oncotarget.28679.


Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model.

Alsalloum A, Alrhmoun S, Perik-Zavosdkaia O, Fisher M, Volynets M, Lopatnikova J Front Immunol. 2024; 15:1507218.

PMID: 39660132 PMC: 11628372. DOI: 10.3389/fimmu.2024.1507218.


Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells.

Patel A, Kutuzov M, Dustin M, Anton van der Merwe P, Dushek O Immunother Adv. 2024; 4(1):ltae004.

PMID: 38978751 PMC: 11228853. DOI: 10.1093/immadv/ltae004.


Pro-inflammatory responses after peptide-based cancer immunotherapy.

Mahaki H, Ravari H, Kazemzadeh G, Lotfian E, Daddost R, Avan A Heliyon. 2024; 10(11):e32249.

PMID: 38912474 PMC: 11190603. DOI: 10.1016/j.heliyon.2024.e32249.


References
1.
Chen L, Flies D . Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013; 13(4):227-42. PMC: 3786574. DOI: 10.1038/nri3405. View

2.
Verbrugge I, Hagekyriakou J, Sharp L, Galli M, West A, McLaughlin N . Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies. Cancer Res. 2012; 72(13):3163-74. DOI: 10.1158/0008-5472.CAN-12-0210. View

3.
Radvanyi L, Bernatchez C, Zhang M, Fox P, Miller P, Chacon J . Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2012; 18(24):6758-70. PMC: 3525747. DOI: 10.1158/1078-0432.CCR-12-1177. View

4.
Youngblood B, Wherry E, Ahmed R . Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr Opin HIV AIDS. 2011; 7(1):50-7. PMC: 3306172. DOI: 10.1097/COH.0b013e32834ddcf2. View

5.
Vali B, Jones R, Sakhdari A, Sheth P, Clayton K, Yue F . HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol. 2010; 40(9):2493-505. DOI: 10.1002/eji.201040340. View